Is the Leukemia and Lymphoma Society a Good Charity?

The Leukemia and Lymphoma Society is the largest voluntary health organization in the United States dedicated to blood cancer. That scale makes it worth examining carefully — large organizations attract large donations, and large donations deserve rigorous accountability.

What LLS actually does

LLS funds blood cancer research, provides patient services including financial assistance and educational resources, and advocates for policies affecting blood cancer patients. Unlike some disease charities that focus exclusively on research, LLS has a significant direct service component that reaches patients regardless of whether research eventually produces cures.

The organization has funded over $1.3 billion in blood cancer research since its founding in 1949. Several treatments now standard in blood cancer care received early funding through LLS, including targeted therapies for chronic myeloid leukemia that have transformed a previously fatal diagnosis into a manageable chronic condition for many patients.

The financial picture

LLS's program expense ratio runs around 75-78% based on recent filings, meaning roughly three quarters of expenditure goes to programs versus administration and fundraising. This is above average for large health charities and meets the threshold most evaluators consider acceptable.

Charity Navigator gives LLS four stars. BBB Wise Giving Alliance finds it meets all accountability standards. GiveWell has not evaluated LLS because its methodology does not apply well to research-funding organizations where outcomes materialize over decades rather than immediately.

The peer-to-peer fundraising model

A significant portion of LLS revenue comes through peer-to-peer fundraising programs — Team in Training, Light the Night, and similar campaigns where individuals raise money from their personal networks. These programs generate substantial revenue but also carry higher fundraising costs than direct mail or major gifts. Donors giving through peer fundraising should understand that a portion of their gift covers the infrastructure of these campaigns.

What makes LLS different from similar organizations

LLS is unusual among disease charities in publishing its research portfolio with grant recipients, amounts, and research objectives. This allows donors to see specifically what research is being funded rather than receiving only aggregate numbers. The organization also publishes outcomes from funded research, connecting specific grants to specific discoveries over time.

This level of research transparency is genuinely uncommon and represents a real accountability mechanism for donors interested in where their research dollars go.

The criticism worth understanding

Some effective altruism researchers have questioned whether funding disease-specific research organizations is the most effective use of charitable dollars compared to giving directly to interventions with immediate, measurable impact. This is a legitimate philosophical question about how to evaluate research funding, not a criticism of LLS's operations or integrity.

For donors motivated by personal connection to blood cancer — through their own diagnosis or that of someone they love — LLS offers a credible, well-run organization with documented research impact and genuine patient services. For donors optimizing purely for near-term measurable lives saved per dollar, other interventions score higher on that specific metric.

The verdict

LLS is a legitimate, financially transparent, and operationally credible organization with a genuine track record in blood cancer research and patient services. Its program ratio is above average, its research transparency is above average, and its independent ratings are strong. It belongs on the short list for donors motivated by blood cancer as a cause.

FundTracker tracks verified charitable organizations with real-time trust scores. Compare active health campaigns from GlobalGiving on our NGO rankings page.